<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">MSJ</journal-id>
<journal-id journal-id-type="hwp">spmsj</journal-id>
<journal-id journal-id-type="nlm-ta">Mult Scler</journal-id>
<journal-title>Multiple Sclerosis Journal</journal-title>
<issn pub-type="ppub">1352-4585</issn>
<issn pub-type="epub">1477-0970</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage UK: London, England</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/1352458512452921</article-id>
<article-id pub-id-type="publisher-id">10.1177_1352458512452921</article-id>
<article-categories>
<subj-group subj-group-type="heading"><subject>Research Papers</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Cortico-muscular coherence as an index of fatigue in multiple sclerosis</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Tomasevic</surname><given-names>L</given-names></name>
<xref ref-type="aff" rid="aff1-1352458512452921">1</xref>
<xref ref-type="aff" rid="aff4-1352458512452921">4</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Zito</surname><given-names>G</given-names></name>
<xref ref-type="aff" rid="aff2-1352458512452921">2</xref>
<xref ref-type="aff" rid="aff1-1352458512452921">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Pasqualetti</surname><given-names>P</given-names></name>
<xref ref-type="aff" rid="aff4-1352458512452921">4</xref>
<xref ref-type="aff" rid="aff2-1352458512452921">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Filippi</surname><given-names>MM</given-names></name>
<xref ref-type="aff" rid="aff4-1352458512452921">4</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Landi</surname><given-names>D</given-names></name>
<xref ref-type="aff" rid="aff3-1352458512452921">3</xref>
<xref ref-type="aff" rid="aff4-1352458512452921">4</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Ghazaryan</surname><given-names>A</given-names></name>
<xref ref-type="aff" rid="aff3-1352458512452921">3</xref>
<xref ref-type="aff" rid="aff4-1352458512452921">4</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Lupoi</surname><given-names>D</given-names></name>
<xref ref-type="aff" rid="aff4-1352458512452921">4</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Porcaro</surname><given-names>C</given-names></name>
<xref ref-type="aff" rid="aff1-1352458512452921">1</xref>
<xref ref-type="aff" rid="aff5-1352458512452921">5</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Bagnato</surname><given-names>F</given-names></name>
<xref ref-type="aff" rid="aff6-1352458512452921">6</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Rossini</surname><given-names>PM</given-names></name>
<xref ref-type="aff" rid="aff2-1352458512452921">2</xref>
<xref ref-type="aff" rid="aff7-1352458512452921">7</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Tecchio</surname><given-names>F</given-names></name>
<xref ref-type="aff" rid="aff1-1352458512452921">1</xref>
<xref ref-type="aff" rid="aff2-1352458512452921">2</xref>
</contrib>
</contrib-group>
<aff id="aff1-1352458512452921"><label>1</label>LET’S–ISTC–CNR, Department of Neuroscience, Fatebenefratelli Hospital—Isola Tiberina, Italy</aff>
<aff id="aff2-1352458512452921"><label>2</label>Department of Neuroimaging, IRCCS San Raffaele Pisana, Italy</aff>
<aff id="aff3-1352458512452921"><label>3</label>Clinical Neurology, University Campus Bio-Medico, Italy</aff>
<aff id="aff4-1352458512452921"><label>4</label>AFaR, Department of Neuroscience, Fatebenefratelli Hospital-Isola Tiberina, Italy</aff>
<aff id="aff5-1352458512452921"><label>5</label>Institute of Neuroscience, Newcastle University, Medical School, UK</aff>
<aff id="aff6-1352458512452921"><label>6</label>Vanderbilt University Institute of Imaging Science, Radiology Department, USA</aff>
<aff id="aff7-1352458512452921"><label>7</label>Clinical Neurology, Catholic University, Italy</aff>
<author-notes>
<corresp id="corresp1-1352458512452921">Franca Tecchio, LET’S–ISTC–CNR, Department of Clinical Neuroscience, Fatebenefratelli Hospital—Isola Tiberina, 00186 Rome, Italy. Email: <email>franca.tecchio@istc.cnr.it</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>3</month>
<year>2013</year>
</pub-date>
<volume>19</volume>
<issue>3</issue>
<fpage>334</fpage>
<lpage>343</lpage>
<history>
<date date-type="received">
<day>1</day>
<month>3</month>
<year>2012</year>
</date>
<date date-type="rev-recd">
<day>23</day>
<month>4</month>
<year>2012</year>
</date>
<date date-type="accepted">
<day>26</day>
<month>5</month>
<year>2012</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s) 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract>
<sec id="section1-1352458512452921">
<title>Background:</title>
<p>Highly common in multiple sclerosis (MS), fatigue severely impacts patients’ daily lives. Previous findings of altered connectivity patterns led to the hypothesis that the distortion of functional connections within the brain-muscle circuit plays a crucial pathogenic role.</p>
</sec>
<sec id="section2-1352458512452921">
<title>Objective:</title>
<p>The objective of this paper is to identify markers sensitive to fatigue in multiple sclerosis.</p>
</sec>
<sec id="section3-1352458512452921">
<title>Methods:</title>
<p>Structural (magnetic resonance imaging with assessment of thalamic volume and cortical thickness of the primary sensorimotor areas) and functional (cortico-muscular coherence (CMC) from simultaneous electroencephalo- and surface electromyographic recordings during a weak handgrip task) measures were used on 20 mildly disabled MS patients (relapsing–remitting course, Expanded Disability Status Scale score ≤ 2) who were recruited in two fatigue-dependent groups according to the Modified Fatigue Index Scale (MFIS) score.</p>
</sec>
<sec id="section4-1352458512452921">
<title>Results:</title>
<p>The two groups were similar in terms of demographic, clinical and imaging features, as well as task execution accuracy and weariness. In the absence of any fatigue-dependent brain and muscular oscillatory activity alterations, CMC worked at higher frequencies as fatigue increased, explaining 67% of MFIS variance (<italic>p</italic>=.002).</p>
</sec>
<sec id="section5-1352458512452921">
<title>Conclusion:</title>
<p>Brain-muscle functional connectivity emerged as a sensitive marker of phenomena related to the origin of MS fatigue, impacting central-peripheral communication well before the appearance of any impairment in the communicating nodes.</p>
</sec>
</abstract>
<kwd-group>
<kwd>Cortical thickness and volumetry</kwd>
<kwd>electroencephalography (EEG)</kwd>
<kwd>fatigue in multiple sclerosis (MS)</kwd>
<kwd>magnetic resonance imaging (MRI)</kwd>
<kwd>surface electromyography (EMG)</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section6-1352458512452921" sec-type="intro">
<title>Introduction</title>
<p>Fatigue is a common and quite disabling symptom in patients with multiple sclerosis (MS). Defined as ‘a subjective lack of physical and or mental energy interfering with usual and desired activities’ (MSCfCP Guidelines, 1998), MS-related fatigue has a dramatic impact on patients’ quality of life even when physical impairment is mild.<sup><xref ref-type="bibr" rid="bibr1-1352458512452921">1</xref></sup> Successful treatments are still lacking, mostly because of poor understanding of the biological substrate of fatigue in MS patients.</p>
<p>The commonly accepted hypothesis ascribes a distinct role to specific sensorimotor networks. Neurophysiological studies employing electroencephalography (EEG) and transcranial magnetic stimulation (TMS) confirmed the involvement of motor cortical structures in MS-fatigued patients compared to non-fatigued ones and/or to healthy subjects. Specifically, MS fatigue has been associated with the failure of the inhibitory mechanisms in frontal<sup><xref ref-type="bibr" rid="bibr2-1352458512452921">2</xref></sup> and primary motor (M1) areas<sup><xref ref-type="bibr" rid="bibr3-1352458512452921">3</xref></sup> as well as increased M1 excitability.<sup><xref ref-type="bibr" rid="bibr4-1352458512452921">4</xref></sup> Brain magnetic resonance imaging (MRI) studies performed with conventional acquisition sequences showed that fatigued patients have higher lesion volume (LV) in the internal capsule, periventricular trigone,<sup><xref ref-type="bibr" rid="bibr5-1352458512452921">5</xref></sup> right parieto-temporal and left frontal regions.<sup><xref ref-type="bibr" rid="bibr6-1352458512452921">6</xref></sup> Total LV was not associated with fatigue when considering the brain as a whole without regional specificity.<sup><xref ref-type="bibr" rid="bibr7-1352458512452921">7</xref></sup> Studies employing non- conventional MRI-derived metrics such as brain atrophy and cortical thickness computations, magnetisation transfer ratio (MTR), diffusion tensor (DT)-derived parameters, proton spectroscopic (1H-MRS) and quantitative MRI converged on the absence of MS fatigue-related alterations on a whole-brain basis.<sup><xref ref-type="bibr" rid="bibr7-1352458512452921">7</xref>,<xref ref-type="bibr" rid="bibr8-1352458512452921">8</xref></sup> Conversely, such differentiations emerged when a region-specific scale was applied.<sup><xref ref-type="bibr" rid="bibr6-1352458512452921">6</xref>,<xref ref-type="bibr" rid="bibr9-1352458512452921">9</xref></sup></p>
<p>Focusing on estimates of cerebral connectivity instead of structural measures, reductions in overall N-acetylaspartate concentrations in fatigued vs. non-fatigued patients pointed toward a diffuse axonal pathology as a possible substrate of MS fatigue.<sup><xref ref-type="bibr" rid="bibr10-1352458512452921">10</xref>,<xref ref-type="bibr" rid="bibr11-1352458512452921">11</xref></sup> Disruption of the cortico-subcortical circuits linking the cortex to the basal ganglia was proposed as a potential mechanism for fatigue by authors employing metabolic imaging techniques such as positron emission tomography<sup><xref ref-type="bibr" rid="bibr12-1352458512452921">12</xref></sup> and functional MRI.<sup><xref ref-type="bibr" rid="bibr13-1352458512452921">13</xref></sup></p>
<p>Convergent imaging and electrophysiological evidence of the sensorimotor system involvement and of the relevance of network inter-node communications in MS fatigue led us to focus on a key connectivity property within the primary motor system: the central-peripheral communication that takes place via the brain-muscle coupling of neural/muscular oscillating rhythmic firing (CMC). To probe the structural properties of the primary motor control system, we measured thalamic volume and cortical thickness of rolandic areas in addition to CMC during a weak handgrip. Particular sensitivity to subtle system alterations is expected for the primary motor system since it is the last station dispatching control signals to execute and monitor fine and accurate hand movements as well as everyday life actions. The concept that nodes belonging to more frequently used wider networks have a higher chance of being impaired after remote damage was also supported by studies in MS.<sup><xref ref-type="bibr" rid="bibr14-1352458512452921">14</xref>,<xref ref-type="bibr" rid="bibr15-1352458512452921">15</xref></sup></p>
<p>The coupling of cortical and muscular rhythmic oscillations<sup><xref ref-type="bibr" rid="bibr16-1352458512452921">16</xref>,<xref ref-type="bibr" rid="bibr17-1352458512452921">17</xref></sup> estimated by beta band coherence (CMC) is expected to be sensitive to MS fatigue. In particular, our working hypothesis that CMC is higher in fatigued vs. non-fatigued MS patients is sustained by integrated data gathered from sensorimotor studies in healthy people and in patients with MS. We observed in healthy subjects that sensory feedback enabling continuous monitoring/corrections required for precise motor execution is mediated by the communication (corollary discharges) between the primary sensory area (S1) and M1.<sup><xref ref-type="bibr" rid="bibr15-1352458512452921">15</xref></sup> Furthermore, a greater number of corrections was needed to maintain motor task performance, and it corresponded to higher levels of CMC.<sup><xref ref-type="bibr" rid="bibr18-1352458512452921">18</xref></sup> Under median nerve sensory stimulation, we observed in MS patients an inadequate M1 responsiveness to the projections from S1.<sup><xref ref-type="bibr" rid="bibr14-1352458512452921">14</xref>,<xref ref-type="bibr" rid="bibr19-1352458512452921">19</xref></sup> Consequently, such an impairment of S1-M1 functional binding might lead to ‘over-corrections’ resulting in easy fatigue and higher levels of CMC than normal. To evaluate the frequencies of corrections needed to perform the required motor task, exerted pressure measured by an ad hoc device underwent proper spectral analysis.</p>
<p>The aim of the present work is the identification of markers sensitive to fatigue in mildly disabled relapsing–remitting (RR) MS patients. Correlation analyses were performed between fatigue scores and electrophysiological and imaging variables. In the case of multiple variables showing significant correlations with fatigue, a regression model was applied to define which index was the best predictor of fatigue.</p>
</sec>
<sec id="section7-1352458512452921" sec-type="methods">
<title>Subjects and methods</title>
<sec id="section8-1352458512452921">
<title>Patients</title>
<p>Twenty RR-MS<sup><xref ref-type="bibr" rid="bibr20-1352458512452921">20</xref></sup> patients were recruited from the MS centre of the department. The study was approved by the Ethical Committee of the Fatebenefratelli Hospital and was performed in accordance with the ethical standards noted in the 1964 Declaration of Helsinki. All subjects signed informed consent prior to their inclusion in the study (see <xref ref-type="table" rid="table1-1352458512452921">Table 1</xref> for clinical and demographic details).</p>
<table-wrap id="table1-1352458512452921" position="float">
<label>Table 1.</label>
<caption><p>MS patient demographic and clinical profile.</p></caption>
<graphic alternate-form-of="table1-1352458512452921" xlink:href="10.1177_1352458512452921-table1.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="left"/>
<col align="char" char="."/>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th align="left">Patient nr.</th>
<th align="left">Sex</th>
<th align="left">Age</th>
<th align="left">DMT</th>
<th align="left">Dis Dur</th>
<th align="left">Rel</th>
<th align="left">EDSS</th>
<th align="left">FSS</th>
<th align="left">MFIS tot</th>
<th align="left">MFIS phys</th>
<th/>
<th align="left">BDI</th>
<th align="left">9-HPT</th>
</tr>
</thead>
<tbody>
<tr>
<td>pat_01</td>
<td>M</td>
<td>36</td>
<td>INF beta1a</td>
<td>8.8</td>
<td>0</td>
<td>1</td>
<td>2.3</td>
<td>5</td>
<td>4</td>
<td/>
<td>5</td>
<td>17.10</td>
</tr>
<tr>
<td>pat_02</td>
<td>F</td>
<td>40</td>
<td>natalizumab</td>
<td>0.6</td>
<td>0</td>
<td>2</td>
<td>3.7</td>
<td>37</td>
<td>19</td>
<td/>
<td>8</td>
<td>19.58</td>
</tr>
<tr>
<td>pat_03</td>
<td>M</td>
<td>38</td>
<td>INF beta1a</td>
<td>2.6</td>
<td>0</td>
<td>1</td>
<td>1.2</td>
<td>8</td>
<td>2</td>
<td/>
<td>0</td>
<td>24.13</td>
</tr>
<tr>
<td>pat_04</td>
<td>F</td>
<td>33</td>
<td>INF beta1a</td>
<td>13.0</td>
<td>1</td>
<td>1.5</td>
<td>2.5</td>
<td>32</td>
<td>9</td>
<td/>
<td>11</td>
<td>16.43</td>
</tr>
<tr>
<td>pat_05</td>
<td>M</td>
<td>42</td>
<td>INF beta1b</td>
<td>0.5</td>
<td>1</td>
<td>1</td>
<td>1.8</td>
<td>33</td>
<td>17</td>
<td/>
<td>8</td>
<td>11.50</td>
</tr>
<tr>
<td>pat_06</td>
<td>F</td>
<td>40</td>
<td>INF beta1b</td>
<td>1.1</td>
<td>1</td>
<td>0</td>
<td>4.5</td>
<td>18</td>
<td>16</td>
<td/>
<td>7</td>
<td>21.41</td>
</tr>
<tr>
<td>pat_07</td>
<td>F</td>
<td>42</td>
<td>INF beta1b</td>
<td>0.6</td>
<td>1</td>
<td>0</td>
<td>5.8</td>
<td>44</td>
<td>20</td>
<td/>
<td>11</td>
<td>11.14</td>
</tr>
<tr>
<td>pat_08</td>
<td>F</td>
<td>47</td>
<td>Cop-1</td>
<td>7.9</td>
<td>0</td>
<td>1</td>
<td>4.1</td>
<td>18</td>
<td>6</td>
<td/>
<td>10</td>
<td>18.38</td>
</tr>
<tr>
<td>pat_09</td>
<td>F</td>
<td>27</td>
<td>INF beta1aCop-1</td>
<td>3.4</td>
<td>1</td>
<td>1</td>
<td>2.4</td>
<td>13</td>
<td>4</td>
<td/>
<td>0</td>
<td>18.52</td>
</tr>
<tr>
<td>pat_10</td>
<td>F</td>
<td>38</td>
<td>INF beta1a</td>
<td>2.2</td>
<td>0</td>
<td>0</td>
<td>5.6</td>
<td>26</td>
<td>21</td>
<td/>
<td>10</td>
<td>20.12</td>
</tr>
<tr>
<td>pat_11</td>
<td>F</td>
<td>37</td>
<td>INF beta1a</td>
<td>7.0</td>
<td>0</td>
<td>0</td>
<td>5.8</td>
<td>39</td>
<td>19</td>
<td/>
<td>1</td>
<td>19.96</td>
</tr>
<tr>
<td>pat_12</td>
<td>F</td>
<td>22</td>
<td>no</td>
<td>2.5</td>
<td>1</td>
<td>0</td>
<td>4.2</td>
<td>30</td>
<td>14</td>
<td/>
<td>12</td>
<td>18.74</td>
</tr>
<tr>
<td>pat_13</td>
<td>F</td>
<td>39</td>
<td>INF beta1a</td>
<td>3.6</td>
<td>0</td>
<td>2</td>
<td>3.1</td>
<td>16</td>
<td>9</td>
<td/>
<td>7</td>
<td>20.14</td>
</tr>
<tr>
<td>pat_14</td>
<td>F</td>
<td>34</td>
<td>INF beta 1b</td>
<td>5.5</td>
<td>0</td>
<td>1.5</td>
<td>6.7</td>
<td>52</td>
<td>29</td>
<td/>
<td>8</td>
<td>19.43</td>
</tr>
<tr>
<td>pat_15</td>
<td>F</td>
<td>42</td>
<td>INF beta1b</td>
<td>9.2</td>
<td>2</td>
<td>1.5</td>
<td>4</td>
<td>18</td>
<td>8</td>
<td/>
<td>4</td>
<td>18.02</td>
</tr>
<tr>
<td>pat_16</td>
<td>M</td>
<td>44</td>
<td>INF beta1a</td>
<td>1.4</td>
<td>2</td>
<td>1.5</td>
<td>1.5</td>
<td>14</td>
<td>5</td>
<td/>
<td>9</td>
<td>19.82</td>
</tr>
<tr>
<td>pat_17</td>
<td>M</td>
<td>41</td>
<td>no</td>
<td>11.1</td>
<td>0</td>
<td>1.5</td>
<td>4.7</td>
<td>43</td>
<td>21</td>
<td/>
<td>12</td>
<td>20.81</td>
</tr>
<tr>
<td>pat_18</td>
<td>F</td>
<td>33</td>
<td>INF beta1b</td>
<td>6.0</td>
<td>0</td>
<td>1</td>
<td>4.7</td>
<td>29</td>
<td>18</td>
<td/>
<td>10</td>
<td>20.67</td>
</tr>
<tr>
<td>pat_19</td>
<td>M</td>
<td>30</td>
<td>INF beta1a</td>
<td>5.2</td>
<td>1</td>
<td>1</td>
<td>4.3</td>
<td>45</td>
<td>23</td>
<td/>
<td>9</td>
<td>18.50</td>
</tr>
<tr>
<td>pat_20</td>
<td>M</td>
<td>24</td>
<td>INF beta1b</td>
<td>2,5</td>
<td>0</td>
<td>0</td>
<td>2,3</td>
<td>12</td>
<td>8</td>
<td/>
<td>4</td>
<td>19,87</td>
</tr>
<tr>
<td><italic>mean</italic></td>
<td><italic>7M</italic></td>
<td><italic>37.2</italic></td>
<td/>
<td><italic>4.7</italic></td>
<td><italic>0.36</italic></td>
<td><italic>0.9</italic></td>
<td><italic>3.6</italic></td>
<td><italic>26.6</italic></td>
<td><italic>14.0</italic></td>
<td/>
<td><italic>7.2</italic></td>
<td><italic>19.1</italic></td>
</tr>
<tr>
<td>(sd)</td>
<td><italic>13F</italic></td>
<td><italic>(6.1)</italic></td>
<td/>
<td><italic>(3.8)</italic></td>
<td><italic>(0.5)</italic></td>
<td><italic>(0.7)</italic></td>
<td><italic>(1.8)</italic></td>
<td><italic>(13.8)</italic></td>
<td><italic>(8.5)</italic></td>
<td/>
<td><italic>(3.9)</italic></td>
<td><italic>(2.6)</italic></td>
</tr>
<tr>
<td><italic>mean</italic></td>
<td><italic>3M</italic></td>
<td><italic>35.9</italic></td>
<td><italic>FatigNo</italic></td>
<td/>
<td><italic>5.5</italic></td>
<td><italic>0.3</italic></td>
<td><italic>1.1</italic></td>
<td><bold><italic>2.5</italic></bold></td>
<td><bold><italic>16.6</italic></bold></td>
<td><bold><italic>6.6</italic></bold></td>
<td><italic>6.2</italic></td>
<td><italic>19.1</italic></td>
</tr>
<tr>
<td>(sd)</td>
<td><italic>6F</italic></td>
<td><italic>(7.8)</italic></td>
<td/>
<td/>
<td><italic>(3.9)</italic></td>
<td><italic>(0.5)</italic></td>
<td><italic>(0.6)</italic></td>
<td><italic>(1.2)</italic></td>
<td><italic>(8.6)</italic></td>
<td><italic>(4.3)</italic></td>
<td><italic>(3.2)</italic></td>
<td><italic>(2.1)</italic></td>
</tr>
<tr>
<td><italic>mean</italic></td>
<td><italic>3M</italic></td>
<td><italic>38.5</italic></td>
<td><italic>FatigYes</italic></td>
<td/>
<td><italic>3.8</italic></td>
<td><italic>0.4</italic></td>
<td><italic>0.8</italic></td>
<td><bold><italic>4.9</italic></bold></td>
<td><bold><italic>36.6</italic></bold></td>
<td><bold><italic>21.3</italic></bold></td>
<td><italic>8.3</italic></td>
<td><italic>19.2</italic></td>
</tr>
<tr>
<td>(sd)</td>
<td><italic>8F</italic></td>
<td><italic>(3.2)</italic></td>
<td/>
<td/>
<td><italic>(3.7)</italic></td>
<td><italic>(0.5)</italic></td>
<td><italic>(0.8)</italic></td>
<td><italic>(1.4)</italic></td>
<td><italic>(10.2)</italic></td>
<td><italic>(4.8)</italic></td>
<td><italic>(3.2)</italic></td>
<td><italic>(3.2)</italic></td>
</tr>
<tr>
<td/>
<td/>
<td>.<italic>353</italic></td>
<td><italic>p=</italic></td>
<td/>
<td>.<italic>360</italic></td>
<td>.<italic>611</italic></td>
<td>.<italic>421</italic></td>
<td><italic>&lt;.001</italic></td>
<td><italic>&lt;.001</italic></td>
<td><italic>&lt;.001</italic></td>
<td>.<italic>242</italic></td>
<td>.<italic>955</italic></td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-1352458512452921">
<p>MS: multiple sclerosis; M: male; F: female; DMT: disease-modifying therapy, INF: interferon, Cop-1: Copolymer-1; Rel: annual relapse rate; Scores of: EDSS: Expanded Disability Status Scale; FSS: Fatigue Severity Scale; MFIS tot: Modified Fatigue Impact Scale; MFIS phys: MFIS physical items; BDI: Beck Depression Inventory; 9-HPT: right-hand 9-Hole Peg Test. Mean and (SD: standard deviations) are presented in italics for the patient group as a whole (light grey background) and separately for the patients who do not (FatigNo, white background) or do (FatigYes, grey background) complain about fatigue. In the last row are significance of inter-group differences of the means; in bold are values differing between the two groups.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>A detailed clinical history inclusive of ongoing disease-modifying therapy (DMT), disease duration and annual relapse rate was collected. Beck Depression Inventory (BDI),<sup><xref ref-type="bibr" rid="bibr21-1352458512452921">21</xref></sup> Expanded Disability Status Scale (EDSS)<sup><xref ref-type="bibr" rid="bibr22-1352458512452921">22</xref></sup> and Nine Hole Peg Test (9-HPT)<sup><xref ref-type="bibr" rid="bibr23-1352458512452921">23</xref></sup> were scored at the time of neurological examination.</p>
<p>Fatigue levels were assessed using the Fatigue Severity Scale (FSS)<sup><xref ref-type="bibr" rid="bibr24-1352458512452921">24</xref></sup> and the Modified Fatigue Impact Scale (MFIS).<sup><xref ref-type="bibr" rid="bibr25-1352458512452921">25</xref></sup> MFIS identifies the physical, cognitive and psychosocial components of fatigue; its sub-score of physical items (MFIS_phys) was considered in the present study in addition to the complete score (MFIS_tot).</p>
<p>Inclusion criteria were as follows: absence of clinical relapse or radiological evidence of disease activity over the last three months; ability to rule out physical disability or depression as confounding factors by EDSS score ≤ 2 and BDI score &lt;13<sup><xref ref-type="bibr" rid="bibr26-1352458512452921">26</xref></sup> as cut-off in recruiting patients. The score of MFIS_phys (total range (0–36)) was used to ensure an equal patient’s distribution in two non-fatigued (FatigNo &lt; 15) and fatigued (FatigYes ≥ 16)<sup><xref ref-type="bibr" rid="bibr27-1352458512452921">27</xref></sup> groups.</p>
<p>The exclusion criteria included: i) assumption of symptomatic drugs which may affect the level of fatigue, depression and anxiety within the past three months;<sup><xref ref-type="bibr" rid="bibr28-1352458512452921">28</xref></sup> ii) epilepsy or other central/peripheral nervous system comorbidities; iii) any systemic conditions that may cause fatigue (e.g. anaemia or pregnancy).</p>
<p>All patients underwent electroencephalography (EEG)-surface electromyography (EMG) sessions within a few days after MRI, ensuring the absence of acute lesions.</p>
</sec>
<sec id="section9-1352458512452921">
<title>MRI exam and measure estimate</title>
<p><italic>Image acquisition</italic>: The acquisition protocol is detailed in <xref ref-type="table" rid="table2-1352458512452921">Table 2</xref>.</p>
<table-wrap id="table2-1352458512452921" position="float">
<label>Table 2.</label>
<caption><p>MRI acquisition protocol.</p></caption>
<graphic alternate-form-of="table2-1352458512452921" xlink:href="10.1177_1352458512452921-table2.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th/>
<th align="left">T1 Spin-echo pre-post Gd<sup><xref ref-type="table-fn" rid="table-fn3-1352458512452921">a</xref></sup></th>
<th align="left">T2 Multi-echo</th>
<th align="left">T1 3D Fast field-echo (MPRAGE)</th>
<th align="left">3D-FLAIR</th>
</tr>
</thead>
<tbody>
<tr>
<td><bold>Field of view (FOV), mm</bold></td>
<td>240</td>
<td>230</td>
<td>240</td>
<td>250</td>
</tr>
<tr>
<td><bold>Repetition time (TR), ms</bold></td>
<td>450</td>
<td>2630</td>
<td>8,6</td>
<td>8000</td>
</tr>
<tr>
<td><bold>Echo time (TE), ms</bold></td>
<td>15</td>
<td>20-40-60-80-100 <sup><xref ref-type="table-fn" rid="table-fn3-1352458512452921">c</xref></sup></td>
<td>4</td>
<td>282</td>
</tr>
<tr>
<td><bold>Inversion time (TI), ms</bold></td>
<td>—</td>
<td>—</td>
<td>—</td>
<td>2400</td>
</tr>
<tr>
<td><bold>Flip angle (FA)</bold></td>
<td>90</td>
<td>90</td>
<td>8</td>
<td>90</td>
</tr>
<tr>
<td><bold>Slice thickness, mm</bold></td>
<td>4</td>
<td>3</td>
<td>1,25</td>
<td>1,2</td>
</tr>
<tr>
<td><bold>Slice gap, mm</bold></td>
<td>0,4</td>
<td>0</td>
<td>0</td>
<td>0</td>
</tr>
<tr>
<td><bold>Nr of slices<sup><xref ref-type="table-fn" rid="table-fn3-1352458512452921">b</xref></sup></bold></td>
<td>28</td>
<td>40</td>
<td>170</td>
<td>180</td>
</tr>
<tr>
<td><bold>Acquisition time, min</bold></td>
<td>2,51</td>
<td>4,54</td>
<td>6,23</td>
<td>8,56</td>
</tr>
<tr>
<td><bold>Plane</bold></td>
<td>axial and coronal</td>
<td>axial</td>
<td>sagittal</td>
<td>sagittal</td>
</tr>
<tr>
<td><bold>Matrix</bold></td>
<td>240×148</td>
<td>256×256</td>
<td>192×192</td>
<td>256×256</td>
</tr>
<tr>
<td><bold>Number of acquisitions</bold></td>
<td>1+1</td>
<td>1</td>
<td>2</td>
<td>1</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn2-1352458512452921">
<p>The protocol was approved by Fondazione Italiana Sclerosi Multipla. Brain MRI was performed with a 1.5 T scanner (Achieva, Philips Medical Systems, Best, The Netherlands), provided with 33 mT/m gradient amplitude, online 2D/3D geometric distortion correction and an eight-channel SENSE coil. Column order reflects the acquisition order, except post-Gd sequences, performed after 3D-FLAIR.</p>
</fn>
<fn id="table-fn3-1352458512452921">
<p>MRI: magnetic resonance imaging; <sup>a</sup>intravenous injection of gadolinium (0.2 mmol/kg); <sup>b</sup>multiple Times of Echo (TEs) were acquired for iron density estimate; <sup>c</sup>only images with echoes 20–100 ms were used for the present study.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<sec id="section10-1352458512452921">
<title>Image post-processing computations</title>
<p><italic>Lesion load</italic>: Tissue damage was quantified by a semi-automated local thresholding approach for region of interest (ROI) identification on T2-weighted images (Jim 5.0, Xinapse Systems Ltd, Leicester, UK). TLV was then computed. To normalise for the inter-subject head volume variability, lesion relative fraction (LrF) was computed as the ratio of the TLV over the white matter (WM) volume (estimated by Structural Image Evaluation, using Normalisation, of Atrophy — SIENAX algorithm, <xref ref-type="fig" rid="fig1-1352458512452921">Figure 1</xref>).</p>
<fig id="fig1-1352458512452921" position="float">
<label>Figure 1.</label>
<caption><p><bold>Neuroradiological variables</bold>.</p>
<p>Jim 5.0 was used for lesion volume mask determination and volume calculation. Freesurfer 5.0 was used for cortical segmentation and thickness estimate (red-filled regions) separately for the left and right rolandic area. FIRST software was used for thalamus volume evaluation.</p></caption>
<graphic xlink:href="10.1177_1352458512452921-fig1.tif"/>
</fig>
<p><italic>Brain Parenchymal Fraction (BPF)</italic>: SIENAX was also used to estimate total brain tissue volume normalised for skull size, segmenting the brain separately from non-brain tissues (<ext-link ext-link-type="uri" xlink:href="http://www.fmrib.ox.ac.uk/fsl/siena">http://www.fmrib.ox.ac.uk/fsl/siena</ext-link>, Smith et al., 2002). Probabilistic brain mask derived in standard space was applied to make sure that certain structures such as eyes/optic nerve were not included in the brain segmentation.</p>
<p><italic>Thalamic volume</italic>: Thalamic volume (<xref ref-type="fig" rid="fig1-1352458512452921">Figure 1</xref>) was estimated by the model-based segmentation/registration tool FIRST, within the FSL 4.1.6 suite (<ext-link ext-link-type="uri" xlink:href="http://www.fmrib.ox.ac.uk/fsl/first">http://www.fmrib.ox.ac.uk/fsl/first</ext-link>, see Patenaude et al., 2011 for details).</p>
<p><italic>Cortical thickness (CTh)</italic>: Regional segmentation and cortical reconstruction were performed with the Freesurfer 5.0 image analysis software.<sup><xref ref-type="bibr" rid="bibr29-1352458512452921">29</xref></sup> Appropriate manual editing was used to correct surface extraction problems due to artefacts or MS lesions at the level of junction between white and grey matter. In agreement with the planned assessment of primary sensorimotor system evaluation, we selected the central sulcus region (lh/rh_S_central_thickness, <xref ref-type="fig" rid="fig1-1352458512452921">Figure 1</xref>) among the overall measures provided by the software.<sup><xref ref-type="bibr" rid="bibr30-1352458512452921">30</xref></sup></p>
</sec></sec>
<sec id="section11-1352458512452921">
<title>Electrophysiological investigation</title>
<p><italic>Experimental paradigm</italic>: In all patients, EEG, surface EMG and electrocardiogram (EKG) were simultaneously recorded using Ag/AgCl electrodes, band pass filtered between 0.48 Hz and 256 Hz, sampled at 1024 Hz and stored on computer for off-line processing. EEG was recorded using a Micromed System Plus SAM32 (Micromed S.p.A., Mogliano Veneto, Italy). The EEG montage comprised 23 channels (standard 19 of 10–20 International EEG system, plus FC4, FC3, CP4, CP3). A medio-frontal reference and an occipital ground were used. Surface EMG of the right and left <italic>opponens pollicis</italic> muscle (EMG<sub>OPr</sub> and EMG<sub>OPl</sub>) was recorded with a belly-tendon montage (2.5 cm inter-electrode distance).</p>
<p><italic>Motor task</italic>: All subjects sat comfortably in a chair (<xref ref-type="fig" rid="fig2-1352458512452921">Figure 2</xref>). They performed a handgrip against resistance of a semi-compliant air-bulb, connected to a digital board hosting in-house-developed electronics that recorded the exerted pressure while giving the subject visual feedback (Interactive Pressure Sensor, InPresS, <xref ref-type="fig" rid="fig2-1352458512452921">Figure 2</xref>). After determining right handgrip maximum voluntary contraction (MVC), a rest period of at least 2 minutes was provided. Then, a tone beep indicated the subject should switch from the 20 s block of weak isometric right handgrip (5% MVC) to a 20 s block of relaxation. The target level was set to 5% MVC to minimise weariness related to the task. A total of 240 s of contraction was recorded to ensure a minimum of 200 s of artefact-free data. The EEG-EMG session lasted about 30 minutes.</p>
<fig id="fig2-1352458512452921" position="float">
<label>Figure 2.</label>
<caption><p><bold>Electrophysiological exam and variables</bold>.</p>
<p>In one representative patient, <bold>left from top</bold>: subject position, with EEG-cap and surface electrodes for EMG recordings. Exerted pressure as measured by InPresS (second row) and EMG<sub>OPr</sub> (third row) during the first and last two periods of contraction and rest of the motor task lasting 8 minutes total. <bold>Right from top</bold>: Visual feedback while performing the task, with periods of rest intermingled to isometric contractions; one second windowed signal of EMG from left and right <italic>opponens pollicis</italic> muscle (second and fourth rows, EMG<sub>OPr</sub> and EMG<sub>OPl</sub>) and from bipolar derivation selected as maximally coherent with contralateral EMG activity (third and fifth rows, EEG<sub>SM1l</sub> and EEG<sub>SM1r</sub>) in the two conditions. In the successive rows, power spectral density function (PSD) in resting periods and during movement in the (1–100) Hz frequency range for EMG<sub>OP</sub> PSD and (1–50) Hz for EEG<sub>SM1</sub> PSD (ordinate scales are fixed across the two conditions). The coherence function between EEG<sub>SM1l</sub> and EMG<sub>OPr</sub> is presented in the (0-50)Hz frequency range during the right handgrip.</p>
<p>EEG: electroencephalography; EMG: surface electromyography.</p></caption>
<graphic xlink:href="10.1177_1352458512452921-fig2.tif"/>
</fig>
<p><italic>Weariness induced by the motor task</italic>: Pressure and EMG variables were used as indicators of weariness induced by the test task (see <xref ref-type="fig" rid="fig3-1352458512452921">Figure 3</xref>).</p>
<fig id="fig3-1352458512452921" position="float">
<label>Figure 3.</label>
<caption><p><bold>Weariness during the motor task.</bold></p>
<p>Dynamic pattern at the beginning (Start) and final task epochs (End) of the average variables were used as indicators of weariness induced by the test task (a reduction of the mean generated pressure, an increase of the mean amplitude with a reduction of the median spectral frequency of the rectified EMG<sub>OPr</sub>; an increase the mean heart rate) across non-fatigued and fatigued patients of [<bold>from top</bold>]: pressure exerted on the bulb during the right isometric handgrip expressed as a percentage of the individual maximal voluntary contraction (MVC); amplitude and median frequency of the rectified right EMG<sub>OP</sub> ; heart rate expressed in bit per minute (bpm). Vertical bars indicate one standard error. No difference was found between the two groups for any variable.</p>
<p>EMG: surface electromyography.</p></caption>
<graphic xlink:href="10.1177_1352458512452921-fig3.tif"/>
</fig>
<p><italic>Performance of the motor task</italic>: The execution quality of the isometric contraction was estimated as the distance from the required pressure level normalised by the mean along the whole period of contraction, excluding the time getting from and to rest (about 2 s altogether).</p>
<p>Since our working hypothesis leads us to expect over-correction of the movement in fatigued vs. non-fatigued patients, we introduced the ratio between pressure Power Spectral Density (PSD) at low and high frequencies to estimate the prevalence of less and more frequent movement corrections (correction rate, lower index values corresponding to more frequent corrections).</p>
<p><italic>CMC estimate</italic>: We estimated the coupling between brain and muscle as the spectral coherence function between the rectified EMG<sub>OPr</sub> and the bipolar EEG derivation<sup><xref ref-type="bibr" rid="bibr31-1352458512452921">31</xref></sup> identified as displaying maximal coherence with the muscle activity (EEG<sub>SM1l</sub>).<sup><xref ref-type="bibr" rid="bibr18-1352458512452921">18</xref></sup> CMC was scored by the amplitude and the frequency of the maximum amplitude peak.</p>
<p>CMC as well as PSD (<xref ref-type="fig" rid="fig2-1352458512452921">Figure 2</xref>) of the EEG<sub>SM1l</sub> and the rectified EMG<sub>OPr</sub> during right handgrip were estimated by the Welch procedure (2048 ms duration, Hanning window, no overlap, number of artefact-free trials fixed across patients).</p>
</sec>
<sec id="section12-1352458512452921">
<title>Statistical analysis</title>
<p>To be closest to the adequate cases-per-variables ratio (CpV = 10) between cases (20) and predictors, the statistical design of our study restricted the number of predicting variables to four, selected on the basis of the working hypothesis: CMC, correction rate, thalamus volume and rolandic cortical thickness (candidate predictors).</p>
<p><italic>Fatigue-dependent group analysis</italic>: Upon assessing the normal distribution of the variables and applying transformations for a better fit when appropriate, <italic>t</italic>-tests for independent samples were used to identify fatigued-dependent group differences. Analysis of variance (ANOVA) for repeated measures was used to investigate spectral properties of EEG<sub>SM1l</sub> and the rectified EMG<sub>OPr</sub> with the between-subjects factor <italic>FatigGroup</italic> (FatigNo, FatigYes<italic>)</italic> and the within-subjects factor <italic>Band</italic> (Delta to High gamma).</p>
<p>Different susceptibility to weariness during the motor task among fatigued and non-fatigued MS patients was studied by a similar ANOVA model applied to the indices of fatigue (namely, pressure, EMG<sub>OP</sub> amplitude and median spectral frequency, heart rate). <italic>Weariness within trial</italic> (first and last 4 s in each period) and <italic>Weariness along session</italic> (first and last two periods of contraction) as within-subject factors were added to the between-subjects factor <italic>FatigGroup</italic>. Using this analysis, a different level of weariness between the two groups would be revealed by significant <italic>FatigGroup</italic> or <italic>FatigGroup*Weariness</italic> (<italic>within trial</italic> or <italic>along session</italic>) factors.</p>
<p><italic>Fatigue-dependent regression analysis</italic>: After assessing the effect of each single candidate predictor on fatigue score, a multiple regression model using fatigue score as the dependent factor and significant variables as the independent factors was computed to derive the amount of fatigue score variance explained by the electrophysiological and neuroradiological variables. To decide whether neuroradiological or task-related weariness or performance variables should be taken into account as potential confounding factors in the regression analysis, we further calculated correlation coefficients between fatigue scores (on one side) and thalamic volume, cortical thickness, performance, exerted pressure, EMG area, EMG median frequency and heart rate (on the other). Any factor with significance <italic>p</italic>&lt;.200 will be entered as covariate.</p>
</sec></sec>
<sec id="section13-1352458512452921" sec-type="results">
<title>Results</title>
<sec id="section14-1352458512452921">
<title>Patients’ clinical picture</title>
<p>As shown in <xref ref-type="table" rid="table1-1352458512452921">Table 1</xref>, the two fatigue-dependent groups were fully comparable in terms of all demographic and clinical features. There were no significant associations between the FSS, MFIS_tot and MFIS_phys and any of the clinical and demographic variables (no correlation with age, disease duration, annual relapse rate, EDSS, or BDI; <italic>p</italic>&gt;.400 consistently). In particular, in analysing fine hand motor control by a 9-HPT test, no difference was present between the two groups (independent sample <italic>t</italic>-test <italic>p</italic>=.949).</p>
<sec id="section15-1352458512452921">
<title>Fatigue-dependent group analysis of neuroradiological and electrophysiological data</title>
<p><italic>Lesion load</italic>: Lesion load did not differ in the two groups, either in terms of total lesion volume, lesion relative fraction or brain parenchymal fraction (<xref ref-type="table" rid="table3-1352458512452921">Table 3</xref>).</p>
<table-wrap id="table3-1352458512452921" position="float">
<label>Table 3.</label>
<caption><p>Neuroradiological measures in the two fatigue-dependent MS patient groups.</p></caption>
<graphic alternate-form-of="table3-1352458512452921" xlink:href="10.1177_1352458512452921-table3.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th/>
<th align="left">TLV (cm<sup>3</sup>)</th>
<th align="left">LrF</th>
<th align="left">BPF</th>
<th align="center" colspan="2">Thalamus V</th>
<th align="center" colspan="2">SM1 Cth</th>
</tr>
<tr>
<th/>
<th/>
<th/>
<th/>
<th align="left">Left (cm<sup>3</sup>)</th>
<th align="left">Right (cm<sup>3</sup>)</th>
<th align="left">Left (mm)</th>
<th align="left">Right (mm)</th>
</tr>
</thead>
<tbody>
<tr>
<td>FatigNo</td>
<td>17.2</td>
<td>0.03</td>
<td>0.81</td>
<td>6.7</td>
<td>6.7</td>
<td>1.73</td>
<td>1.67</td>
</tr>
<tr>
<td/>
<td>(8.1)</td>
<td>(0.03)</td>
<td>(0.02)</td>
<td>(1.1)</td>
<td>(1.1)</td>
<td>(0.18)</td>
<td>(0.18)</td>
</tr>
<tr>
<td>FatigYes</td>
<td>11.0</td>
<td>0.02</td>
<td>0.82</td>
<td>7.2</td>
<td>7.4</td>
<td>1.71</td>
<td>1.70</td>
</tr>
<tr>
<td/>
<td>(8.3)</td>
<td>(0.01)</td>
<td>(0.01)</td>
<td>(1.2)</td>
<td>(1.4)</td>
<td>(0.07)</td>
<td>(0.09)</td>
</tr>
<tr>
<td><italic>p</italic></td>
<td>.<italic>142</italic></td>
<td>.<italic>323</italic></td>
<td>.<italic>212</italic></td>
<td colspan="2">.<italic>719</italic></td>
<td colspan="2">.<italic>914</italic></td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn4-1352458512452921">
<p>MS: multiple sclerosis. In the two fatigue-dependent groups, mean (SD: standard deviation) of total lesion volume (TLV), lesion relative fraction (LrF), brain parenchymal factor (BPF, dimensionless), left and right thalamic volume (Thalamus V) and cortical thickness in the central sulcus (SM1 Cth) were estimated separately in the two hemispheres. No differences were observed between the two groups for any variable as indicated by significance (<italic>p</italic>) of independent sample <italic>t</italic>-test (TLV, LrF, BPF) or main between-subjects factor <italic>FatigGroup</italic> (Thalamus V, SM1 Cth).</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p><italic>Thalamic volume</italic>: Thalamic volumes were studied by ANOVA with <italic>Hemisphere</italic> (right, left) as the within-subject factor and <italic>FatigGroup</italic> (FatigNo, FatigYes) as the between-subject factor. No significant effect was evidenced (see <xref ref-type="table" rid="table3-1352458512452921">Table 3</xref> for between-subject factor; <italic>Hemisphere p</italic>=.734; <italic>Hemisphere</italic>*<italic>FatigGroup p</italic>=.179).</p>
<p><italic>Cortical thickness</italic>: Cortical thickness in the rolandic sulcus, studied by a similar ANOVA model as for thalamic volume, did not differ in the two groups (<xref ref-type="table" rid="table3-1352458512452921">Table 3</xref>). No effects were observed between the left and right SM1 rolandic areas (<italic>Hemisphere</italic> (<italic>p</italic>=.120)) or their interaction (<italic>p</italic>=.251).</p>
<p>Fatigue scores did not correlate with any neuroradiological variable (TLV, LrF, BPF, mean between left and right Thalamus V and SM1_Cth; <italic>p</italic>&gt;.200 consistently for any of MFIS_tot, MFIS_phys, FSS).</p>
<p><italic>Weariness during the motor task</italic>: None of the main <italic>Fatigue</italic> or interaction <italic>Fatigue</italic>
<sub>*</sub><italic>Weariness</italic> (<italic>within trial</italic> or <italic>along session</italic>) factors were significant for the pressure level, the amplitude or median spectral frequency of the EMG<sub>OPr</sub> or heart rate (<italic>p</italic>&gt;.200 consistently, <xref ref-type="fig" rid="fig3-1352458512452921">Figure 3</xref>), excluding task-induced weariness as a source of difference between fatigued and non-fatigued MS patients.</p>
<p><italic>Performance of the motor task</italic>: The two fatigue-dependent patient groups did not differ regarding the quality of the executed task (<xref ref-type="table" rid="table4-1352458512452921">Table 4</xref>). On the contrary, fatigued patients corrected the exerted pressure more frequently than did non-fatigued ones, as evidenced by lower correction rate index values (<xref ref-type="table" rid="table4-1352458512452921">Table 4</xref>).</p>
<table-wrap id="table4-1352458512452921" position="float">
<label>Table 4.</label>
<caption><p>Motor execution indices in the two fatigue-dependent groups.</p></caption>
<graphic alternate-form-of="table4-1352458512452921" xlink:href="10.1177_1352458512452921-table4.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th/>
<th align="center" colspan="2">CMC</th>
<th align="left">Task performance</th>
<th align="left">Correction rate</th>
</tr>
<tr>
<th/>
<th align="left">Freq (Hz)</th>
<th align="left">Amp</th>
<th/>
<th/>
</tr>
</thead>
<tbody>
<tr>
<td>FatigNo</td>
<td><bold>16.7</bold></td>
<td>.06</td>
<td>0.05</td>
<td><bold>2.20</bold></td>
</tr>
<tr>
<td/>
<td>(3.6)</td>
<td>(.05)</td>
<td>(0.04)</td>
<td>(0.55)</td>
</tr>
<tr>
<td>FatigYes</td>
<td><bold>27.5</bold></td>
<td>.07</td>
<td>0.03</td>
<td><bold>1.40</bold></td>
</tr>
<tr>
<td/>
<td>(4.8)</td>
<td>(.02)</td>
<td>(0.02)</td>
<td>(0.38)</td>
</tr>
<tr>
<td><italic>t-</italic>test <italic>p</italic></td>
<td><italic>&lt;.001</italic></td>
<td>.<italic>720</italic></td>
<td>.<italic>412</italic></td>
<td>.<italic>006</italic></td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn5-1352458512452921">
<p>During right isometric handgrip, mean (SD: standard deviation) of the cortico-muscular coherence (CMC) frequency (Freq) of the maximal amplitude peak (Amp, dimensionless) and of the ratio between the exerted pressure power at low and high frequencies (correction rate). Values differing between the two groups of fatigued and non-fatigued patients are bold in accordance with independent <italic>t</italic>-test two-tailed significance.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p><italic>CMC during right handgrip</italic>: At least 226 s of artefact-free data were obtained, so that the CMC and PSD estimates were calculated on a number of epochs set to 110 across patients. Independent sample <italic>t</italic>-tests indicated that fatigued patients expressed CMC at higher frequencies than did non-fatigued patients (<xref ref-type="table" rid="table4-1352458512452921">Table 4</xref>; <xref ref-type="fig" rid="fig4-1352458512452921">Figure 4</xref>). No difference was found for CMC amplitude (<xref ref-type="table" rid="table4-1352458512452921">Table 4</xref>).</p>
<fig id="fig4-1352458512452921" position="float">
<label>Figure 4.</label>
<caption><p><bold>CMC and task execution dependency on MS fatigue</bold>.</p>
<p>For representative patients of each fatigue-dependent group, left: the coherence function between EEGSM1l and EMGOPr (full black dots represented on the right lay-figure) during the right handgrip is presented in the (0–50)Hz frequency range, horizontal line indicating significance level. Fatigued patients displayed CMC peaks at higher frequencies than non-fatigued patients. Right: power spectral density function (PSD) of the pressure exerted on the InPresS bulb. Fatigued patients displayed higher power for low frequencies and lower power for high frequencies than non-fatigued patients. The discriminating point between low and high frequencies was selected for each subject when the first derivative became stable within 10% of the difference between its maximum and minimum in 0–90 Hz.</p>
<p>EEG: electroencephalography; EMG: surface electromyography; CMC: cortico-muscular coherence.</p></caption>
<graphic xlink:href="10.1177_1352458512452921-fig4.tif"/>
</fig>
<p>ANOVAs with <italic>Band</italic> as the within-subject factor and <italic>Fatigue</italic> as the between-subject factor were applied to the rectified EMG<sub>OPr</sub> and the EEG<sub>SM1l</sub> PSDs. No effects were found (<italic>p</italic>&gt;.500 consistently).</p>
<p>No variable among task performance, exerted pressure, EMG<sub>OP</sub> amplitude, EMG<sub>OP</sub> median frequency or heart rate (the means across periods of contraction and along the session for weariness variables) was correlated with fatigue scores (<italic>p</italic>&gt;.300 consistently).</p>
</sec>
<sec id="section16-1352458512452921">
<title>Fatigue-explaining regression analysis</title>
<p>Since no neuroradiological fatigue predictors differed between the two fatigue-dependent groups, only CMC peak frequency and pressure correction were studied in regression with fatigue scores (<xref ref-type="table" rid="table5-1352458512452921">Table 5</xref>). CMC_Freq and pressure correction indices were included as independent variables in the regression model with MFIS_phys as the dependent variable. Only CMC_freq entered the model as expressed by MFIS_phys = -8.374 + 0.968 CMC_Freq. Sixty-seven percent of the variance was explained by CMC_freq [F(1,9)=18.059, <italic>p</italic>=.002].</p>
<table-wrap id="table5-1352458512452921" position="float">
<label>Table 5.</label>
<caption><p>Motor execution indices in relationship with fatigue scores.</p></caption>
<graphic alternate-form-of="table5-1352458512452921" xlink:href="10.1177_1352458512452921-table5.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="left"/>
<col align="char" char="."/>
<col align="char" char="."/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th/>
<th/>
<th align="left">MFIS_tot</th>
<th align="left">MFIS_Phys</th>
<th align="left">FSS</th>
</tr>
</thead>
<tbody>
<tr>
<td>CMC_Freq</td>
<td><italic>r</italic></td>
<td>.<bold>773</bold></td>
<td>.<bold>771</bold></td>
<td>.
<bold>737</bold></td>
</tr>
<tr>
<td/>
<td>(<italic>p</italic>)</td>
<td>(.005)</td>
<td>(.001)</td>
<td>(.003)</td>
</tr>
<tr>
<td>Correction</td>
<td><italic>r</italic></td>
<td>−.307</td>
<td>−.<bold><italic>551</italic></bold></td>
<td><bold>−.645</bold></td>
</tr>
<tr>
<td>rate</td>
<td>(<italic>p</italic>)</td>
<td>(.247)</td>
<td>(.027)</td>
<td>(.007)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn6-1352458512452921">
<p>Pearson coefficient (<italic>r</italic>) and two-tailed significance (<italic>p</italic>) of the correlation between the fatigue scale scores and the cortico-muscular coherence frequency (CMC_Freq) and the index indicating the frequency of pressure corrections during the right isometric handgrip. Bold values indicate significance at the .01 level and italic at .05. MFIS_tot: Modified Fatigue Impact Scale; MFIS_Phys: MFIS physical items; FSS: Fatigue Severity Scale.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>Our working hypothesis led us to expect that CorrRate explained fatigue more than CMC_freq. On the contrary, CorrRate did not enter the regression model. It is noteworthy that central-peripheral communication frequency increased as pressure corrections became more frequent (Pearson’s correlation between CorrRate and CMC_freq <italic>r</italic>=−.643, <italic>p</italic>=.033).</p>
</sec>
</sec>
</sec>
<sec id="section17-1352458512452921" sec-type="discussion">
<title>Discussion</title>
<p>Results obtained thus far have shown that only indices related to movement execution are significantly associated with fatigue, rather than morpho-structural measures related to primary sensorimotor network. Specifically, fatigued patients expressed cortico-muscular coupling at faster frequencies, and they corrected at higher frequencies the pressure they exerted during handgrip. Previous results from our group yielded the hypothesis that cortico-muscular coupling would have been higher in amplitude in fatigued compared to non-fatigued patients because of a condition of continuous request of movement over-correction induced by an altered sensory feedback.<sup><xref ref-type="bibr" rid="bibr14-1352458512452921">14</xref></sup> We derived from healthy people the expectation of higher CMC amplitude, but our MS patients showed CMC higher in frequency, not in amplitude. In particular, CMC amplitude in MS patients was similar to findings already published in a population of young adults executing the same task (.08 ± .04, 10 subjects with age range 21–35 years).<sup><xref ref-type="bibr" rid="bibr18-1352458512452921">18</xref></sup> It was previously described that in tasks with force levels changing over time, the cortico-muscular coupling works at higher frequencies than when force levels are constant over time.<sup><xref ref-type="bibr" rid="bibr32-1352458512452921">32</xref></sup> For an MS-fatigued patient, data suggest, simple isometric contractions become more complex movements, continuously changing over time.</p>
<p>Fatigued patients corrected the movement more frequently, but that was not the reason they were fatigued. In fact, most of the fatigue was explained by CMC frequency. Both correction rate index and CMC frequency were associated with fatigue, but the latter solely entered the regression model. Therefore, functional communication within the central-peripheral nervous system is sensitive to subtle brain organisation changes leading to fatigue, much more so than the consequent alterations occurring in the movement control. In dystonic patients, CMC was enhanced in amplitude and did not vary in frequency, revealing that these features of the brain-muscle communication keep track of the different disease pathophysiology. In particular, the absence of CMC frequency changes in dystonic patients suggests that MS fatigue impacts the control of common everyday motor tasks more than the dystonic condition (testing motor tasks that do not induce dystonic movements). While both dystonic<sup><xref ref-type="bibr" rid="bibr15-1352458512452921">15</xref></sup> and MS<sup><xref ref-type="bibr" rid="bibr14-1352458512452921">14</xref></sup> cortical responses to peripheral nerve stimulation are characterised by a reduced M1 responsiveness to S1 projection, in dystonic patients we did not observe the distortion of the response morphology found in MS patients, marking a disruption of primary somatosensory network patterning in MS.<sup><xref ref-type="bibr" rid="bibr14-1352458512452921">14</xref></sup> These observations seem to indicate that the intra-cortical synchronisation phenomena sustaining the efficacious communication between S1 and M1<sup><xref ref-type="bibr" rid="bibr28-1352458512452921">28</xref></sup> also significantly affect the cortico-muscular coupling implicated in motor control. In healthy people undergoing fatiguing tasks, the CMC tested by a non-fatiguing task increased in amplitude and not in frequency,<sup><xref ref-type="bibr" rid="bibr33-1352458512452921">33</xref></sup> emphasising that the MS-fatigue condition is not directly mirrored in muscle fatigue induced in the healthy condition.<sup><xref ref-type="bibr" rid="bibr34-1352458512452921">34</xref>,<xref ref-type="bibr" rid="bibr35-1352458512452921">35</xref></sup></p>
<p>CMC was shown to be a sensitive marker of MS-related fatigue in patients with minimal physical impairment and whose MRI measures of white matter and grey matter disease failed to explain at least part of the variance of the fatigue scores. CMC sensitivity to MS fatigue may originate from its power to probe functional connectivity upon long distance, frequently engaged sensorimotor control networks. In support of this hypothesis, our data provided the concurrent finding that spectral features of both motor cortex and muscular oscillatory activities were completely unaltered by fatigue, revealing that the quality of communication is possibly the intimate nature of the impairment before any alteration emerges in the communicating nodes. Both normal ‘upstream’ (cortex) and ‘downstream’(muscle) electrical activity, in contrast with distortion of their functional connection (cortico-muscular coupling), reveal MS fatigue emerging from a central-peripheral communication distortion. A further distortion of neuronal communication can be recognised intra-cortically, where traces of altered S1-M1 connectivity pattern were documented in MS.<sup><xref ref-type="bibr" rid="bibr14-1352458512452921">14</xref></sup> This impoverished synchronisation of sensory and motor network node activities points towards a crucial role of sensory-motor integration at the origin of MS fatigue. Full comparability of the present fatigue-dependent cohorts for clinical severity, disease history (duration and annual relapses), age, fine hand motor control (9-HPT) and lesion load make the present study a solid beginning for understanding the originating mechanisms of MS-related fatigue.</p>
<p>Absence of fatigue depending on the cortical thickness within the central sulcus and thalamic volume could be in agreement with very recent data on the parietal lobe involvement in explaining fatigue symptoms.<sup><xref ref-type="bibr" rid="bibr9-1352458512452921">9</xref>,<xref ref-type="bibr" rid="bibr27-1352458512452921">27</xref></sup></p>
<p>As future steps, the efficacy of neuromodulation interventions against MS fatigue can be tested as long as they are able to properly modify functional connectivity within the sensorimotor system. Further, the conclusion would be strengthened with observations in larger cohorts.</p>
</sec>
<sec id="section18-1352458512452921" sec-type="conclusions">
<title>Conclusions</title>
<p>The integration of brain-muscle functional connectivity and fine hand motor control features with network structural and functional features revealed the alteration of central-peripheral communication as a pathophysiological substrate of MS fatigue. This finding may open the door for novel therapeutic and rehabilitative strategies.</p>
</sec>
</body>
<back>
<ack>
<p>The authors thank Matilde Ercolani for excellent electrophysiological recording support. We are also sincerely grateful to all our patients for their time and cooperation.</p>
</ack>
<fn-group>
<fn fn-type="financial-disclosure">
<label>Funding statement</label>
<p>This work was supported by FISM – Fondazione Italiana Sclerosi Multipla (grant numbers Cod.2010/R/38, Cod.2011/R/32) and by the Royal Society International Joint Project (grant number 2010/R1).</p>
</fn>
<fn fn-type="conflict">
<label>Conflict of interest statement</label>
<p>The authors declare that there are no conflicts of interest.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-1352458512452921">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Krupp</surname><given-names>LB</given-names></name>
</person-group>. <article-title>Fatigue in multiple sclerosis: definition, pathophysiology and treatment</article-title>. <source>CNS Drugs</source> <year>2003</year>; <volume>17</volume>: <fpage>225</fpage>–<lpage>234</lpage>.</citation>
</ref>
<ref id="bibr2-1352458512452921">
<label>2.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Leocani</surname><given-names>L</given-names></name>
<name><surname>Colombo</surname><given-names>B</given-names></name>
<name><surname>Magnani</surname><given-names>G</given-names></name>
<etal/>
</person-group>. <article-title>Fatigue in multiple sclerosis is associated with abnormal cortical activation to voluntary movement—EEG evidence</article-title>. <source>Neuroimage</source> <year>2001</year>; <volume>13</volume>: <fpage>1186</fpage>–<lpage>1192</lpage>.</citation>
</ref> <ref id="bibr3-1352458512452921">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Liepert</surname><given-names>J</given-names></name>
<name><surname>Mingers</surname><given-names>D</given-names></name>
<name><surname>Heesen</surname><given-names>C</given-names></name>
<etal/>
</person-group>. <article-title>Motor cortex excitability and fatigue in multiple sclerosis: a transcranial magnetic stimulation study</article-title>. <source>Mult Scler</source> <year>2005</year>; <volume>11</volume>: <fpage>316</fpage>–<lpage>321</lpage>.</citation>
</ref> <ref id="bibr4-1352458512452921">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Thickbroom</surname><given-names>GW</given-names></name>
<name><surname>Sacco</surname><given-names>P</given-names></name>
<name><surname>Kermode</surname><given-names>AG</given-names></name>
<etal/>
</person-group>. <article-title>Central motor drive and perception of effort during fatigue in multiple sclerosis</article-title>. <source>J Neurol</source> <year>2006</year>; <volume>253</volume>: <fpage>1048</fpage>–<lpage>1053</lpage>.</citation>
</ref> <ref id="bibr5-1352458512452921">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Colombo</surname><given-names>B</given-names></name>
<name><surname>Martinelli Boneschi</surname><given-names>F</given-names></name>
<name><surname>Rossi</surname><given-names>P</given-names></name>
<etal/>
</person-group>. <article-title>MRI and motor evoked potential findings in nondisabled multiple sclerosis patients with and without symptoms of fatigue</article-title>. <source>J Neurol</source> <year>2000</year>; <volume>247</volume>: <fpage>506</fpage>–<lpage>509</lpage>.</citation>
</ref> <ref id="bibr6-1352458512452921">
<label>6.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sepulcre</surname><given-names>J</given-names></name>
<name><surname>Masdeu</surname><given-names>JC</given-names></name>
<name><surname>Goni</surname><given-names>J</given-names></name>
<etal/>
</person-group>. <article-title>Fatigue in multiple sclerosis is associated with the disruption of frontal and parietal pathways</article-title>. <source>Mult Scler</source> <year>2009</year>; <volume>15</volume>: <fpage>337</fpage>–<lpage>344</lpage>.</citation>
</ref> <ref id="bibr7-1352458512452921">
<label>7.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bakshi</surname><given-names>R</given-names></name>
<name><surname>Miletich</surname><given-names>RS</given-names></name>
<name><surname>Henschel</surname><given-names>K</given-names></name>
<etal/>
</person-group>. <article-title>Fatigue in multiple sclerosis: cross-sectional correlation with brain MRI findings in 71 patients</article-title>. <source>Neurology</source> <year>1999</year>; <volume>53</volume>: <fpage>1151</fpage>–<lpage>1153</lpage>.</citation>
</ref> <ref id="bibr8-1352458512452921">
<label>8.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Codella</surname><given-names>M</given-names></name>
<name><surname>Rocca</surname><given-names>MA</given-names></name>
<name><surname>Colombo</surname><given-names>B</given-names></name>
<etal/>
</person-group>. <article-title>Cerebral grey matter pathology and fatigue in patients with multiple sclerosis: a preliminary study</article-title>. <source>J Neurol Sci</source> <year>2002</year>; <volume>194</volume>: <fpage>71</fpage>–<lpage>74</lpage>.</citation>
</ref> <ref id="bibr9-1352458512452921">
<label>9.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Pellicano</surname><given-names>C</given-names></name>
<name><surname>Gallo</surname><given-names>A</given-names></name>
<name><surname>Li</surname><given-names>X</given-names></name>
<etal/>
</person-group>. <article-title>Relationship of cortical atrophy to fatigue in patients with multiple sclerosis</article-title>. <source>Arch Neurol</source> <year>2010</year>; <volume>67</volume>: <fpage>447</fpage>–<lpage>453</lpage>.</citation>
</ref>
<ref id="bibr10-1352458512452921">
<label>10.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Tartaglia</surname><given-names>MC</given-names></name>
<name><surname>Narayanan</surname><given-names>S</given-names></name>
<name><surname>Francis</surname><given-names>SJ</given-names></name>
<etal/>
</person-group>. <article-title>The relationship between diffuse axonal damage and fatigue in multiple sclerosis</article-title>. <source>Arch Neurol</source> <year>2004</year>; <volume>61</volume>: <fpage>201</fpage>–<lpage>207</lpage>.</citation>
</ref>
<ref id="bibr11-1352458512452921">
<label>11.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Tellez</surname><given-names>N</given-names></name>
<name><surname>Alonso</surname><given-names>J</given-names></name>
<name><surname>Rio</surname><given-names>J</given-names></name>
<etal/>
</person-group>. <article-title>The basal ganglia: a substrate for fatigue in multiple sclerosis</article-title>. <source>Neuroradiology</source> <year>2008</year>; <volume>50</volume>: <fpage>17</fpage>–<lpage>23</lpage>.</citation>
</ref>
<ref id="bibr12-1352458512452921">
<label>12.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Roelcke</surname><given-names>U</given-names></name>
<name><surname>Kappos</surname><given-names>L</given-names></name>
<name><surname>Lechner-Scott</surname><given-names>J</given-names></name>
<etal/>
</person-group>. <article-title>Reduced glucose metabolism in the frontal cortex and basal ganglia of multiple sclerosis patients with fatigue: a 18F-fluorodeoxyglucose positron emission tomography study</article-title>. <source>Neurology</source> <year>1997</year>; <volume>48</volume>: <fpage>1566</fpage>–<lpage>1571</lpage>.</citation>
</ref>
<ref id="bibr13-1352458512452921">
<label>13.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Filippi</surname><given-names>M</given-names></name>
<name><surname>Tortorella</surname><given-names>C</given-names></name>
<name><surname>Rovaris</surname><given-names>M</given-names></name>
</person-group>. <article-title>Magnetic resonance imaging of multiple sclerosis</article-title>. <source>J Neuroimaging</source> <year>2002</year>; <volume>12</volume>: <fpage>289</fpage>–<lpage>301</lpage>.</citation>
</ref>
<ref id="bibr14-1352458512452921">
<label>14.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Dell'Acqua</surname><given-names>ML</given-names></name>
<name><surname>Landi</surname><given-names>D</given-names></name>
<name><surname>Zito</surname><given-names>G</given-names></name>
<etal/>
</person-group>. <article-title>Thalamocortical sensorimotor circuit in multiple sclerosis: an integrated structural and electrophysiological assessment</article-title>. <source>Hum Brain Mapp</source> <year>2010</year>; <volume>31</volume>: <fpage>1588</fpage>–<lpage>1600</lpage>.</citation>
</ref>
<ref id="bibr15-1352458512452921">
<label>15.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Tecchio</surname><given-names>F</given-names></name>
<name><surname>Melgari</surname><given-names>JM</given-names></name>
<name><surname>Zappasodi</surname><given-names>F</given-names></name>
<etal/>
</person-group>. <article-title>Sensorimotor integration in focal task-specific hand dystonia: a magnetoencephalographic assessment</article-title>. <source>Neuroscience</source> <year>2008</year>; <volume>154</volume>: <fpage>563</fpage>–<lpage>571</lpage>.</citation>
</ref>
<ref id="bibr16-1352458512452921">
<label>16.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Conway</surname><given-names>BA</given-names></name>
<name><surname>Halliday</surname><given-names>DM</given-names></name>
<name><surname>Farmer</surname><given-names>SF</given-names></name>
<etal/>
</person-group>. <article-title>Synchronization between motor cortex and spinal motoneuronal pool during the performance of a maintained motor task in man</article-title>. <source>J Physiol</source> <year>1995</year>; <volume>489</volume> (<issue>Pt 3</issue>): <fpage>917</fpage>–<lpage>924</lpage>.</citation>
</ref>
<ref id="bibr17-1352458512452921">
<label>17.</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Piper</surname><given-names>HE</given-names></name>
</person-group>. <source>Elektrophysiologie menschlicher Muskeln</source>. <publisher-loc>Berlin</publisher-loc>: <publisher-name>J Springer</publisher-name>, <year>1912</year>.</citation>
</ref>
<ref id="bibr18-1352458512452921">
<label>18.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Graziadio</surname><given-names>S</given-names></name>
<name><surname>Basu</surname><given-names>A</given-names></name>
<name><surname>Tomasevic</surname><given-names>L</given-names></name>
<etal/>
</person-group>. <article-title>Developmental tuning and decay in senescence of oscillations linking the corticospinal system</article-title>. <source>J Neurosci</source> <year>2010</year>; <volume>30</volume>: <fpage>3663</fpage>–<lpage>3674</lpage>.</citation>
</ref>
<ref id="bibr19-1352458512452921">
<label>19.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Tecchio</surname><given-names>F</given-names></name>
<name><surname>Zito</surname><given-names>G</given-names></name>
<name><surname>Zappasodi</surname><given-names>F</given-names></name>
<etal/>
</person-group>. <article-title>Intra-cortical connectivity in multiple sclerosis: a neurophysiological approach</article-title>. <source>Brain</source> <year>2008</year>; <volume>131</volume>: <fpage>1783</fpage>–<lpage>1792</lpage>.</citation>
</ref>
<ref id="bibr20-1352458512452921">
<label>20.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lublin</surname><given-names>FD</given-names></name>
<name><surname>Reingold</surname><given-names>SC</given-names></name>
</person-group>. <article-title>Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis</article-title>. <source>Neurology</source> <year>1996</year>; <volume>46</volume>: <fpage>907</fpage>–<lpage>911</lpage>.</citation>
</ref>
<ref id="bibr21-1352458512452921">
<label>21.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Beck</surname><given-names>AT</given-names></name>
<name><surname>Ward</surname><given-names>CH</given-names></name>
<name><surname>Mendelson</surname><given-names>M</given-names></name>
<etal/>
</person-group>. <article-title>An inventory for measuring depression</article-title>. <source>Arch Gen Psychiatry</source> <year>1961</year>; <volume>4</volume>: <fpage>561</fpage>–<lpage>571</lpage>.</citation>
</ref>
<ref id="bibr22-1352458512452921">
<label>22.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kurtzke</surname><given-names>JF</given-names></name>
</person-group>. <article-title>Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)</article-title>. <source>Neurology</source> <year>1983</year>; <volume>33</volume>: <fpage>1444</fpage>–<lpage>1452</lpage>.</citation>
</ref>
<ref id="bibr23-1352458512452921">
<label>23.</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Mathiowetz</surname><given-names>V</given-names></name>
<name><surname>Volland</surname><given-names>G</given-names></name>
<name><surname>Kashman</surname><given-names>N</given-names></name>
<etal/>
</person-group>. <article-title>Nine hole peg test [NHPT]</article-title> In: <person-group person-group-type="editor">
<name><surname>Wade</surname><given-names>DT</given-names></name>
</person-group> <source>Measurement in neurological rehabilitation</source>. <publisher-loc>New York</publisher-loc>: <publisher-name>Oxford University Press</publisher-name>, <year>1985</year>, p.<fpage>171</fpage>.</citation>
</ref>
<ref id="bibr24-1352458512452921">
<label>24.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Krupp</surname><given-names>LB</given-names></name>
<name><surname>LaRocca</surname><given-names>NG</given-names></name>
<name><surname>Muir-Nash</surname><given-names>J</given-names></name>
<etal/>
</person-group>. <article-title>The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus</article-title>. <source>Arch Neurol</source> <year>1989</year>; <volume>46</volume>: <fpage>1121</fpage>–<lpage>1123</lpage>.</citation>
</ref>
<ref id="bibr25-1352458512452921">
<label>25.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kos</surname><given-names>D</given-names></name>
<name><surname>Nagels</surname><given-names>G</given-names></name>
<name><surname>D’Hooghe</surname><given-names>MB</given-names></name>
<etal/>
</person-group>. <article-title>A rapid screening tool for fatigue impact in multiple sclerosis</article-title>. <source>BMC Neurol</source> <year>2006</year>; <volume>6</volume>: <fpage>27</fpage>.</citation>
</ref>
<ref id="bibr26-1352458512452921">
<label>26.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sullivan</surname><given-names>MJ</given-names></name>
<name><surname>Weinshenker</surname><given-names>B</given-names></name>
<name><surname>Mikail</surname><given-names>S</given-names></name>
<etal/>
</person-group>. <article-title>Screening for major depression in the early stages of multiple sclerosis</article-title>. <source>Can J Neurol Sci</source> <year>1995</year>; <volume>22</volume>: <fpage>228</fpage>–<lpage>231</lpage>.</citation>
</ref>
<ref id="bibr27-1352458512452921">
<label>27.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Riccitelli</surname><given-names>G</given-names></name>
<name><surname>Rocca</surname><given-names>MA</given-names></name>
<name><surname>Forn</surname><given-names>C</given-names></name>
<etal/>
</person-group>. <article-title>Voxelwise assessment of the regional distribution of damage in the brains of patients with multiple sclerosis and fatigue</article-title>. <source>AJNR Am J Neuroradiol</source> <year>2011</year>; <volume>32</volume>: <fpage>874</fpage>–<lpage>879</lpage>.</citation>
</ref>
<ref id="bibr28-1352458512452921">
<label>28.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rietberg</surname><given-names>MB</given-names></name>
<name><surname>van Wegen</surname><given-names>EE</given-names></name>
<name><surname>Uitdehaag</surname><given-names>BM</given-names></name>
<etal/>
</person-group>. <article-title>The association between perceived fatigue and actual level of physical activity in multiple sclerosis</article-title>. <source>Mult Scler</source> <year>2011</year>; <volume>17</volume>: <fpage>1231</fpage>–<lpage>1237</lpage>.</citation>
</ref>
<ref id="bibr29-1352458512452921">
<label>29.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Fischl</surname><given-names>B</given-names></name>
<name><surname>van der Kouwe</surname><given-names>A</given-names></name>
<name><surname>Destrieux</surname><given-names>C</given-names></name>
<etal/>
</person-group>. <article-title>Automatically parcellating the human cerebral cortex</article-title>. <source>Cereb Cortex</source> <year>2004</year>; <volume>14</volume>: <fpage>11</fpage>–<lpage>22</lpage>.</citation>
</ref>
<ref id="bibr30-1352458512452921">
<label>30.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Desikan</surname><given-names>RS</given-names></name>
<name><surname>Segonne</surname><given-names>F</given-names></name>
<name><surname>Fischl</surname><given-names>B</given-names></name>
<etal/>
</person-group>. <article-title>An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest</article-title>. <source>Neuroimage</source> <year>2006</year>; <volume>31</volume>: <fpage>968</fpage>–<lpage>980</lpage>.</citation>
</ref>
<ref id="bibr31-1352458512452921">
<label>31.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Schnitzler</surname><given-names>A</given-names></name>
<name><surname>Timmermann</surname><given-names>L</given-names></name>
<name><surname>Gross</surname><given-names>J</given-names></name>
</person-group>. <article-title>Physiological and pathological oscillatory networks in the human motor system</article-title>. <source>J Physiol Paris</source> <year>2006</year>; <volume>99</volume>: <fpage>3</fpage>–<lpage>7</lpage>.</citation>
</ref>
<ref id="bibr32-1352458512452921">
<label>32.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kristeva</surname><given-names>R</given-names></name>
<name><surname>Patino</surname><given-names>L</given-names></name>
<name><surname>Omlor</surname><given-names>W</given-names></name>
</person-group>. <article-title>Beta-range cortical motor spectral power and corticomuscular coherence as a mechanism for effective corticospinal interaction during steady-state motor output</article-title>. <source>Neuroimage</source> <year>2007</year>; <volume>36</volume>: <fpage>785</fpage>–<lpage>792</lpage>.</citation>
</ref>
<ref id="bibr33-1352458512452921">
<label>33.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Tecchio</surname><given-names>F</given-names></name>
<name><surname>Porcaro</surname><given-names>C</given-names></name>
<name><surname>Zappasodi</surname><given-names>F</given-names></name>
<etal/>
</person-group>. <article-title>Cortical short-term fatigue effects assessed via rhythmic brain-muscle coherence</article-title>. <source>Exp Brain Res</source> <year>2006</year>; <volume>174</volume>: <fpage>144</fpage>–<lpage>151</lpage>.</citation>
</ref>
<ref id="bibr34-1352458512452921">
<label>34.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bigland-Ritchie</surname><given-names>B</given-names></name>
<name><surname>Woods</surname><given-names>JJ</given-names></name>
</person-group>. <article-title>Changes in muscle contractile properties and neural control during human muscular fatigue</article-title>. <source>Muscle Nerve</source> <year>1984</year>; <volume>7</volume>: <fpage>691</fpage>–<lpage>699</lpage>.</citation>
</ref>
<ref id="bibr35-1352458512452921">
<label>35.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sheean</surname><given-names>GL</given-names></name>
<name><surname>Murray</surname><given-names>NM</given-names></name>
<name><surname>Rothwell</surname><given-names>JC</given-names></name>
<etal/>
</person-group>. <article-title>An electrophysiological study of the mechanism of fatigue in multiple sclerosis</article-title>. <source>Brain</source> <year>1997</year>; <volume>120</volume> (<issue>Pt 2</issue>): <fpage>299</fpage>–<lpage>315</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>